Abstract: Mesenchymal Stem Cells (MSCs) have been isolated from a variety of fetal and adult tissues and are considered an ideal source for cell-based therapy due to their unique properties such as multipotency and immunomodulatory functions. The aim of this work is to observe, analyze and investigate the morphology and proliferation of human dental pulp stem cells cultured in two different culture media: Fetal Bovine Serum (FBS) or platelet lysate. These cells would be cultured for a minimum period of 14 days to 3 months. The desired outcome is a pure culture of mesenchymal stem cells. With this present study we will determine which culture mediumpromotesthe most rapid formation of a pure culture of mesenchymal stem cells derived from Dental Pulp Stem Cells (DPSC).
Introduction
Stem cells are undifferentiated cells that are able to undergo an indefinite number of cell cycles, are capable of self-renewal and can produce highly specialized cells (Ramalho-Santos and Willenbring, 2007) . Recently stem cells have raised a lot of interest in the medical field. Many researchers and clinicians are now studying the possible uses of these cells as precursors of osteoblasts for bone regeneration and the application of these cells in tissue-engineering (Seong et al., 2010; Khanna-Jain et al., 2012) . Dentistry has started to explore the potential applications of stem cells to regenerate and repair compromised dental structures (Amabile and Meissner, 2009) . A new and recent source of mesenchymal stem cells has been found in deciduous teeth; in particular, the dental pulp of deciduous teeth, which is the object of this study (Miura et al., 2003) .
Objectives
The objective of this study is to compare the results of two trials. Both methods shared the same protocol, the only difference being the use of two different culture media. We want to analyze how dental pulp stem cells behave when grown with fetal bovine serum compared to platelet lysate.
Materials and Methods
The subjects of this experiment are dental pulp stem cells extracted from 9 deciduous second mandibular molars extracted from patients aged 9-10 years.
Each tooth is collected and placed in a 50 mL Falcon tube containing pasteurized cow milk at a temperature of 4°C, in order to sustain and support mammalian cells health and functionality. Milk is highly regulated for content sterility and production specification. It also has antibacterial, antifungal, antiviral and antiparasite properties (Olson et al., 1997; Fagade, 2004) .
After verifying the integrity of the pulp chamber and roots, the dental pulp was extracted. The pulp was then transferred into a 50 mL falcon tube filled with PBS (phosphate buffered saline) (Suchánek et al., 2007) .
All living cellular material is isolated from the tooth upon arrival using a mechanical method. Secondarily a chemical selection process occurs which promotes the health and viability of MSC's and retards the growth and health of all other cell types. This process can take as long as 21 days depending on the individual sample. The final step is testing to make sure the final material passes all requirements for cellular identity and subsequent cryopreservation.
Protocol A
After a first phase of centrifugation, enzymatic digestion, burker count and cytofluorimetric characterization the cells were then put in culture for the amplification process (Suchánek et al., 2007) .
The cells that have been obtained are then put in flasks (T75cm2 BD Falcon and T25cm2 BD Falcon) and cultured in Dulbecco's Modified Eagle Medium (DMEM) low glucose with sodium pyruvate culture (Biowest) added with 5% platelet lysate, 1% Lglutamine (Gibco) and 1% penicillin and streptomycin (Gibco) (Anitua, 2001; Lucarelli et al., 2003) .
Before adding the platelet lysate to the culture, heparin was added at the concentration of 2U/ML. The culture was then finally filtered with 0.22micron filters.
The flasks are then incubated at the temperature of 37°C with 5%CO₂. The first culture change is done after 24-48h and the rest of the culture changes every 72 h (Suchanek et al., 2009) .
Five platelet donors were randomly selected to prepare the platelet lysate. The extracted platelets were then centrifuged in order to have a concentration of 1.5 ×10 5 . After the centrifugation process, separate portions were prepared. Each portion underwent three freezing processes at -80°C and three de-freezing processes at 37°C. Ultimately a centrifugation at 300rmp for 20 min was performed and the supernatant was collected in order to collect PRP (platelet rich plasma) (Landesberg et al., 2000; Marx et al., 1998) .
The next steps have been done to verify the identity, proliferation and vitality of DPSC cells cultured with platelet lysate.
The DPSC put in culture are analyzed with surface antigens through a cytomety test (FACS Calibure flow cytometer BD bioscience). Monoclonal antibodies against CD90, CD105, CD31 and CD45 were utilized. The antibodies are added to the population of 100,000 cells and then incubated for 30 min at a temperature of 4°C in the dark. After incubation, the cells are washed and analyzed with acytometry test (Martens et al., 2012) .
The vitality and proliferation of DPSC is analyzed after 14 days in culture. The cells that have been put in culture are incubated in a Dulbecco's Phosphate Buffered Saline (DPBS) solution containing 0.5 mM of calcein Am (green fluorescence) and 0.5 mm ethidiumhomodimer (red fluorescence) for 45 min at the temperature of 28°C. The solution of DPBS that was utilized is then replaced with new DPBS. The vital cells are colored in green while the necrotic cells are colored in red by the fluorescence microscopy test (Abdullah et al., 2014) .
Protocol a Results
The results of this first phase of the study have shown the presence of ahematopoietic CD45+ component, both in the pre-manipulation and postmanipulation process with a media percentage of 1.13+/-0.61 in the pre-manipulation phase and of 13.5+/-5.72 in the post-manipulation phase. In the culture media that was enriched with platelet lysate at 5% there was evidence of megacarioblast aggregates and the cytoflurmetric characterization showed that in four of the experiments post-amplification a media percentage of CD61 (b3 integrin) equal to 2.02+/-1.47. An increase in the expression of any mesenchymal marker was not seen (Table 1) .
In the experiments 4 to 9 there are significant changes in the presence of some cell populations with respect to others. In particular there is a higher percentage of cells with CD45+ characteristics and a lower percentage of CD90, CD 105positive cells (Table 2 ). These results suggest that experimental population of cells obtained in vitro isa mixed population and does not represent the characteristics of a pure mesenchymal stem cell population that was expected to be seen (Karamzadeh et al., 2012) .
Protocol B
The same study has been performed but with some variations in the protocol regarding the use of a different culture media. Fetal Bovine Serum (FBS) was used instead of platelet lysate.
The FBS method followed the same protocol used for the first experiment except the cells are this time transferred in T75 Falcon tubes with Phosphate Buffered Saline (PBS) and after 3 hours put in culture at 37°C with 5% CO₂ with growth factors containing 15% FBS, 100 mm L ascorbic acid, 2 mm of L glutamine and 100U/ml of penicillin and 100 mg/mL of streptomycin in the modified alpha form of eagle.
Results Using Protocol B
This protocol involved the use of FBS instead of the platelet lysate. The following chart represents acytofluorimetricanalysis (Fig. 1) . The preliminary results of the experiments demonstrate that the use of FBS 15% instead of the platelet lysate gave a positive outcome for a selection of mesenchymal cells. After a first phase of amplification the cell population had typical characteristic of mesenchymal cells, which is expressed by a high positivity to markers such as CD90 E CD45. These markers are positive in more than 80% of the cell population that have been tested. 
Discussion
This study comparing the results of two laboratory culture methods represents the first phase of a long scientific analysis that considers the dental pulp stem cells for future utilization in clinical therapy.
Even though different articles state that the use of platelet lysate promotes and increases the proliferation of dental pulp mesenchymal stems cells (Schallmoser et al., 2007; Bieback et al., 2009) and can efficiently substitute for the use of fetal bovine serum in clinical trials, our experiment verified that fetal bovine serum as a culture medium produces a more pure culture of mesenchymal cells than a culture medium of platelet lysate (Azouna et al., 2012; Doucet et al., 2005; Lee et al., 2011) .
The results of these experiments put into perspective how the use of platelet lysate influenced the growth of hematopoietic cell line instead of a stromal cell line. In fact, after the initial phase of amplification the first experimental population of cells showed fewer cells with stromal characteristics and more cells with megacarioblast characteristics. This data may be helpful in understanding the factors that influence the dynamics of cell growth and proliferation induced by different culture media such as platelet lysate and FBS.
The data suggests that platelet lysate is not a preferred culture medium for dental pulp stem cell proliferation. When FBS was used instead almost the entire population of cells had acquired characteristics of "stemness" confirmed by the high positivity to the marker CD90 and negativity to the CD45 marker, typical of the stromal lineage.
In relation to the initial objectives of this study we can state the following: The amplification of a population of pure mesenchymal stem cells has been observed only when fetal bovine serum was used as a culture media. When platelet lysate was used we observed a mixed cell culture with a prevalence of megacaryoblast-like cells and a lack of expected mesenchymal stem cells that could be considered for future clinical purposes.
Conclusion
The identification of mesenchymal cells with ectodermic characteristics is a topic of serious interest for future clinical therapies. This cell population, presenting a primordial nature, could be utilized for retro-inductive protocols to an embryonic condition that would guarantee a vast spectrum of therapeutic uses.
Through the analysis of the experiments we can confirm that the results of our study, that FBS is a better culture medium than platelet lysate for the production of a pure mesenchymal stem cell population, should be considered, even though preliminary, when establishing future clinical and therapeutic research protocols.
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